Total trials
67
Active
16
Phase 3
14
Total enrollment
104,764
Pipeline matrix
Showing 8 of 8 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| cisplatin, gemcitabine | — | — | — | — | — | 1 | |
| Early Vasopressin | — | — | — | — | — | 1 | |
| Norepinephrine and Vasopressin for Rescue | — | — | — | — | — | 1 | |
| Cardiovascular Polypill | — | — | — | — | — | 1 | |
| Colchicine 0.5 mg | — | — | — | — | — | 1 | |
| Usual Care Group | — | — | — | — | — | 1 | |
| Colchicine-placebo 0.5 mg | — | — | — | — | — | 1 | |
| Vasopressin | — | — | — | — | — | 1 |
Next readouts
- 2025-10-10
- 2026-12-31
- 2027-08
- 2031-05
Top conditions
- Covid194
- Familial Hypercholesterolemia3
- Obesity3
- Coronary Artery Disease3
- Cardiovascular Diseases3
- Acute Respiratory Distress Syndrome3
- Heart Failure3
- Depression2
Frequently asked questions about Hospital do Coracao
- How many clinical trials does Hospital do Coracao have on ClinicalTrials.gov?
- Hospital do Coracao is listed as the lead sponsor on 67 clinical trials in ClinicalTrials.gov, 16 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Hospital do Coracao's trials are in Phase 3?
- 14 of Hospital do Coracao's trials are in Phase 3, spread across 8 active drug programs.
- What therapeutic areas does Hospital do Coracao focus on?
- Hospital do Coracao's most-studied conditions on ClinicalTrials.gov are Covid19, Familial Hypercholesterolemia, Obesity, Coronary Artery Disease, Cardiovascular Diseases.
- When are Hospital do Coracao's next clinical trial readouts?
- Hospital do Coracao has 4 upcoming primary-completion readouts tracked here; the soonest is “Use of Vasopressin in Patients at High Risk of Acute Kidney Injury Admitted to the ICU”, expected around 2025-10-10.